Get the Stockscreener App
33.83
0.16%
0.08
Royalty Pharma Plc stock is traded at $33.83, with a volume of 838.34K.
It is up +0.16% in the last 24 hours and up +0.34% over the past month.
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
See More
Previous Close:
$33.75
Open:
$33.85
24h Volume:
838.34K
Relative Volume:
0.22
Market Cap:
$14.62B
Revenue:
$2.27B
Net Income/Loss:
$1.15B
P/E Ratio:
13.27
EPS:
2.55
Net Cash Flow:
$2.80B
1W Performance:
+1.18%
1M Performance:
+0.34%
6M Performance:
+22.26%
1Y Performance:
+11.64%
1-Day Range:
$33.63
$33.91
1-Week Range:
$33.15
$33.99
52-Week Range:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Name
Royalty Pharma Plc
Sector
Industry
Phone
(212) 883-0200
Address
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.80 | 14.62B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.61 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.19 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
287.68 | 37.54B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ARGX
Argen X Se Adr
|
608.20 | 37.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ONC
Beigene Ltd Adr
|
252.80 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Downgrade | UBS | Buy → Neutral |
| Jun-14-22 | Resumed | UBS | Buy |
| May-13-22 | Initiated | Scotiabank | Sector Outperform |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-14-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Oct-29-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-30-21 | Initiated | Tigress Financial | Buy |
| Nov-09-20 | Upgrade | UBS | Neutral → Buy |
| Jul-14-20 | Initiated | Evercore ISI | In-line |
| Jul-13-20 | Initiated | BofA Securities | Buy |
| Jul-13-20 | Initiated | Citigroup | Neutral |
| Jul-13-20 | Initiated | Cowen | Outperform |
| Jul-13-20 | Initiated | Goldman | Neutral |
| Jul-13-20 | Initiated | JP Morgan | Neutral |
| Jul-13-20 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-13-20 | Initiated | SunTrust | Buy |
| Jul-13-20 | Initiated | UBS | Neutral |
View All
Royalty Pharma Plc Stock (RPRX) Latest News
15 Best Defensive Stocks Amid Market Volatility - Insider Monkey
Sciencast Management LP Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Royal London Asset Management Ltd. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat
Fox Run Management L.L.C. Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Thrivent Financial for Lutherans Raises Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Technical Data - Stock Traders Daily
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Twin Tree Management LP - MarketBeat
Horizon Kinetics Asset Management LLC Purchases 90,380 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Swiss National Bank Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Koss Olinger Consulting LLC Invests $269,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - Barchart
Raymond James Financial Inc. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
How Do Investors Really Feel About Royalty Pharma? - Benzinga
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Simply Wall St
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Tredje AP fonden - MarketBeat
Atria Investments Inc Sells 20,550 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jupiter Asset Management Ltd. Invests $4.95 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AGF Management Ltd. Buys Shares of 98,512 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wealthfront Advisers LLC Buys 178,173 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Amundi Trims Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
River Road Asset Management LLC Trims Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Machina Capital S.A.S. Sells 12,740 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Proficio Capital Partners LLC Makes New $786,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Trims Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Victory Capital Management Inc. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Menlo Advisors LLC - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Holdings Lifted by New South Capital Management Inc. - MarketBeat
Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Metis Global Partners LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Plato Investment Management Ltd - MarketBeat
Truist Financial Corp Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Cuts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Principal Financial Group Inc. Has $513,000 Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Torray Investment Partners LLC Has $17.45 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
SBI Securities Co. Ltd. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc Stock (RPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):